Korean Circ J.  2018 Nov;48(11):1000-1001. 10.4070/kcj.2018.0193.

Treat or Not to Treat Non-culprit Coronary Artery with Significant Stenosis during Primary Percutaneous Coronary Intervention

• Lee SJ
• Kim JS

• KMID: 2422547
• DOI: http://doi.org/10.4070/kcj.2018.0193

Abstract

No abstract available.

MeSH Terms

Constriction, Pathologic*
Coronary Vessels*
Percutaneous Coronary Intervention*

Reference

1. Hannan EL, Samadashvili Z, Walford G, et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv. 2010; 3:22–31.

2. Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013; 369:1115–1123.

3. Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015; 65:963–972.

4. Engstrøm T, Kelbæk H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015; 386:665–671.

5. Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2016; 67:1235–1250.

6. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33:2569–2619.

7. Kwon SW, Park SD, Moon J, et al. Complete versus culprit-only revascularization for ST-segment elevation myocardial infarction and multivessel disease in the 2nd generation drug-eluting stent era: data from the INTERSTELLAR registry. Korean Circ J. 2018; 48:989–999.

8. Kim I, Kim MC, Jeong HC, et al. Optimal timing of percutaneous coronary intervention for nonculprit vessel in patients with ST-segment elevation myocardial infarction and multivessel disease. Korean Circ J. 2017; 47:36–43.